Blood test could offer new window into deadly brain tumors
NCT ID NCT05925218
Summary
This study aims to develop a better 'liquid biopsy'—a blood test—to monitor high-grade brain tumors without repeated surgeries. Researchers will collect blood samples from 70 patients before and after their radiation treatment to see if tumor DNA in the blood can be reliably detected and tracked over time. The goal is to create a sensitive tool for understanding how these aggressive brain tumors change and respond to therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH GRADE GLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Health Network
Toronto, Ontario, L4W4C2, Canada
Conditions
Explore the condition pages connected to this study.